<DOC>
	<DOCNO>NCT02866084</DOCNO>
	<brief_summary>This non-randomized pilot study test efficacy neuromodulation via caloric stimulation vestibular migraine . All subject meet study criterion active treatment group . All subject report frequency migraine undergo periodic testing symptom .</brief_summary>
	<brief_title>Neuromodulation Treatment Vestibular Migraines</brief_title>
	<detailed_description>This non-blinded , non-randomized pilot study individual vestibular migraine . The goal test efficacy neuromodulation migraine dizziness symptom patient document vestibular migraine . Treatment consist 9 month active treatment follow 3 month observation . The active treatment require two daily 20 minute session wear device ear deliver small amount warm air ear . All subject undergo series test baseline discrete interval 1 year observation . Primary Secondary endpoint list : â€¢ Primary Efficacy Endpoints 1 . Reduction frequency severity migraine headache ( self report pain diary ) 2 . Reduction frequency intensity perceive vestibular symptom ( Dizziness Handicap Inventory ( DHI ) , Activity Balance confidence scale ( ABC ) , Oscillopsia Test , Symptoms questionnaire ) , OVRT Goggle profile . Secondary Efficacy Endpoints Pilot Study 1 . Improvement sleep quality and/or quantity assess Epworth Sleep Scale . 2 . Improvement quality life assess HIT-6 survey . 3 . Improvement mood/anxiety assess T2 Mood Tracker app ( National Center Telehealth &amp; Technology ) .</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>1 . Adults , age 18 75 diagnosed VM least 3 month prior enter study . 2 . The Investigator must confidence patient 's ability reliably use CVS Device complete requirement study . 1. pregnant 2. history cardiovascular disease 3. work night shift 4. history unstable mood disorder unstable anxiety disorder 5. use hearing aid 6. cochlear implant 7. abuse alcohol drug 8. experience Medication Overuse Headaches ( individual respect Investigator concerned analgesic abuse involve base ICHDII guideline ) . 9. eye surgery within previous three month ear surgery within previous six month 10. active ear infection perforate tympanic membrane 11. participate another clinical trial within last 30 day currently enrol another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>vestibular migraine</keyword>
	<keyword>dizziness</keyword>
	<keyword>migraine headache</keyword>
</DOC>